A Clinical Study to Evaluate the Safety and Efficacy of Aliskiren Alone and in Combination With Ramipril in Hypertensive, Diabetic Patients.

NCT00219089 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

839

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension, Diabetes Mellitus

Interventions

DRUG: aliskiren

Sponsor

Novartis